Legal Opinion
Rapid Litigation Management Ltd. v. CellzDirect, Inc.
Court of Appeals for the Federal Circuit
Decided July 5, 2016No. 2015-1570PublishedCited by 145 opinions
1Opinion of the Court
PROST, Chief Judge.
Appellants seek review of the district court’s summary judgment determination that U.S. Patent No. 7,604,929 (“’929 patent”) is invalid under 35 U.S.C. § 101. The district court concluded that the ’929 patent is directed to a patent-ineligible law of nature — that hepatoeytes are capable of surviving multiple freeze-thaw cycles — and that the patented process lacks the requisite inventive concept. Celsis In Vitro, Inc. v. CellzDirect, Inc., 83 F.Supp.3d 774 (N.D. Ill. 2015), supplemented, 94 F.Supp.3d 940 (N.D. Ill. 2015). Because the ’929 patent claims are not directed to…
2Cases cited14 opinions
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.Supreme Court of the United States · 2012
- Diamond v. DiehrSupreme Court of the United States · 1981
- Gottschalk v. BensonSupreme Court of the United States · 1972
- Association for Molecular Pathology v. Myriad Genetics, Inc.Supreme Court of the United States · 2013
- CyberSource Corp. v. Retail Decisions, Inc.Court of Appeals for the Federal Circuit · 2011
9 more not listed; retrieve them via the Exa API.
3Cited by145 opinions
- Electric Power Group, LLC v. Alstom S.A.Court of Appeals for the Federal Circuit · 2016
- McRO, Inc. v. Bandai Namco Games America Inc.Court of Appeals for the Federal Circuit · 2016
- Chargepoint, Inc. v. Semaconnect, Inc.Court of Appeals for the Federal Circuit · 2019
- Fairwarning Ip, LLC v. Iatric Systems, Inc.Court of Appeals for the Federal Circuit · 2016
- Thales Visionix Inc. v. United StatesCourt of Appeals for the Federal Circuit · 2017
140 more not listed; retrieve them via the Exa API.